VS

Vikas Sharma

Active Director Whole-Time Director DIN 08810122
DIN 08810122 First appointment Jul 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Total affiliations 5 Since Jul 2020
Shareholding value •••• Premium profile

About Vikas Sharma

Data last updated:

Vikas Sharma is a Whole-Time Director at Acme Formulation Private Limited (since 2020), Whole-Time Director at Acme Generics Private Limited (since 2021) and Whole-Time Director at Immacule Lifesciences Private Limited (since 2021), and holds 2 more current directorships. The companies operate in Pharma, Chemicals and Financial Services. The 5 current companies with reported revenue have a combined latest revenue of ₹987 Cr; the largest is Acme Formulation Private Limited at ₹577 Cr (FY 2025).

DIN 08810122
Primary Designation Whole-Time Director
Industry Pharma
First Appointment 29 Jul 2020
Oldest Company Age 22 yrs
Largest company Acme Formulation Private Limited · ₹577 Cr (FY 2025)
Combined revenue ₹987 Cr across 5 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Acme Formulation Private Limited U24230HP2004PTC027223
Whole-Time Director29 Jul 20202004₹577 Cr (FY 2025)Active
Acme Generics Private Limited U24100PB2021PTC056566
Whole-Time Director05 Aug 20212021₹264 Cr (FY 2024)Active
Whole-Time Director31 Aug 20212010₹143 Cr (FY 2025)Active
Ace Invest Private Limited U74900CH2013PTC034318
Director30 Sep 20212013₹2.03 Cr (FY 2025)Active
Director30 Sep 20212009₹1.03 Cr (FY 2025)Active

Board colleagues of Vikas Sharma

Directorship timeline

Open interactive timeline →
Acme Generics Private Limited
Acme Formulation Private Limited
Ace Testing Solutions Private Limited
Ace Invest Private Limited
Premium access

Shareholding and investment profile for Vikas Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vikas Sharma

Vikas Sharma currently holds 5 directorships: Acme Formulation Private Limited (Whole-Time Director, since 29 Jul 2020, revenue ₹577 Cr (FY 2025)); Acme Generics Private Limited (Whole-Time Director, since 05 Aug 2021, revenue ₹264 Cr (FY 2024)); Immacule Lifesciences Private Limited (Whole-Time Director, since 31 Aug 2021, revenue ₹143 Cr (FY 2025)); Ace Invest Private Limited (Director, since 30 Sep 2021, revenue ₹2.03 Cr (FY 2025)); Ace Testing Solutions Private Limited (Director, since 30 Sep 2021, revenue ₹1.03 Cr (FY 2025)).

Vikas Sharma was first appointed on 29 Jul 2020 as Whole-Time Director at Acme Formulation Private Limited. The most recent appointment on record is 30 Sep 2021 at Ace Testing Solutions Private Limited.

The 5 current companies of Vikas Sharma that report revenue have a combined latest revenue of ₹987 Cr: Acme Formulation Private Limited ₹577 Cr (FY 2025); Acme Generics Private Limited ₹264 Cr (FY 2024); Immacule Lifesciences Private Limited ₹143 Cr (FY 2025); Ace Invest Private Limited ₹2.03 Cr (FY 2025); Ace Testing Solutions Private Limited ₹1.03 Cr (FY 2025).

The current boards of Vikas Sharma's companies include Aswin Vikram (Acme Formulation Private Limited), Ginny Uppal (Acme Formulation Private Limited), Nikhil Kumar Srivastava (Acme Formulation Private Limited), Viral Shah (Acme Formulation Private Limited), Viral Shah (Immacule Lifesciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available